Your browser doesn't support javascript.
loading
B7-H3 drives immunosuppression and Co-targeting with CD47 is a new therapeutic strategy in ß-catenin activated melanomas.
Hsu, Min; Martin, Tiphaine C; Vyas, Nikki S; Desman, Garrett; Mendelson, Karen; Horst, Basil; Parsons, Ramon E; Celebi, Julide Tok.
Afiliación
  • Hsu M; Department of Dermatology, NYU Grossman School of Medicine, New York, New York, USA.
  • Martin TC; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Vyas NS; Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Desman G; Department of Dermatology, NYU Grossman School of Medicine, New York, New York, USA.
  • Mendelson K; Department of Dermatology, NYU Grossman School of Medicine, New York, New York, USA.
  • Horst B; Department of Dermatology, NYU Grossman School of Medicine, New York, New York, USA.
  • Parsons RE; Department of Pathology, The University of British Columbia, Vancouver, British Columbia, Canada.
  • Celebi JT; Department of Oncological Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
Pigment Cell Melanoma Res ; 36(5): 407-415, 2023 09.
Article en En | MEDLINE | ID: mdl-37086018
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Melanoma Límite: Humans Idioma: En Revista: Pigment Cell Melanoma Res Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Melanoma Límite: Humans Idioma: En Revista: Pigment Cell Melanoma Res Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos